Amedica Company Profile (NASDAQ:AMDA)

About Amedica (NASDAQ:AMDA)

Amedica logoAmedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AMDA
  • CUSIP: N/A
  • Web: www.amedica.com
Capitalization:
  • Market Cap: $8.45 million
  • Outstanding Shares: 26,402,000
Average Prices:
  • 50 Day Moving Avg: $0.38
  • 200 Day Moving Avg: $0.50
  • 52 Week Range: $0.30 - $1.62
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.80
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $16.67 million
  • Price / Sales: 0.51
  • Book Value: $0.66 per share
  • Price / Book: 0.48
Profitability:
  • EBIDTA: ($8,810,000.00)
  • Net Margins: -91.52%
  • Return on Equity: -116.87%
  • Return on Assets: -48.27%
Debt:
  • Current Ratio: 1.54%
  • Quick Ratio: 0.94%
Misc:
  • Average Volume: 501,294 shs.
  • Beta: -2.3
  • Short Ratio: 3.54
 

Frequently Asked Questions for Amedica (NASDAQ:AMDA)

What is Amedica's stock symbol?

Amedica trades on the NASDAQ under the ticker symbol "AMDA."

How were Amedica's earnings last quarter?

Amedica Co. (NASDAQ:AMDA) posted its quarterly earnings data on Thursday, August, 11th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.09. The business had revenue of $4 million for the quarter, compared to analyst estimates of $4.20 million. Amedica had a negative return on equity of 116.87% and a negative net margin of 91.52%. View Amedica's Earnings History.

Where is Amedica's stock going? Where will Amedica's stock price be in 2017?

1 brokerages have issued twelve-month price targets for Amedica's stock. Their predictions range from $5.00 to $5.00. On average, they anticipate Amedica's stock price to reach $5.00 in the next twelve months. View Analyst Ratings for Amedica.

Who are some of Amedica's key competitors?

Who are Amedica's key executives?

Amedica's management team includes the folowing people:

  • B. Sonny Bal M.D., Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
  • Bryan J. McEntire, Chief Technology Officer
  • Dana Lyons, Vice President - Sales and Marketing
  • Eric A. Stookey, Independent Director
  • David W. Truetzel CPA, Independent Director
  • Jeffrey S. White, Independent Director

How do I buy Amedica stock?

Shares of Amedica can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amedica's stock price today?

One share of Amedica stock can currently be purchased for approximately $0.32.


MarketBeat Community Rating for Amedica (NASDAQ AMDA)
Community Ranking:  5.0 out of 5 (    )
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  0 (Vote Underperform)
Total Votes:  45
MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Amedica (NASDAQ:AMDA) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (1,462.50% upside)

Analysts' Ratings History for Amedica (NASDAQ:AMDA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/24/2017Maxim GroupReiterated RatingBuy$5.00LowView Rating Details
1/5/2016Ladenburg Thalmann Financial ServicesInitiated CoverageBuy$0.35N/AView Rating Details
11/14/2015Needham & Company LLCReiterated RatingBuy$1.00N/AView Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Amedica (NASDAQ:AMDA)
Earnings by Quarter for Amedica (NASDAQ:AMDA)
Earnings History by Quarter for Amedica (NASDAQ:AMDA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016Q316($0.20)($0.30)$4.11 million$3.40 millionViewN/AView Earnings Details
8/11/2016Q216($0.31)($0.40)$4.20 million$4.00 millionViewListenView Earnings Details
5/12/2016Q116($0.25)($0.30)$4.98 million$4.20 millionViewListenView Earnings Details
11/12/2015Q315($0.06)($0.15)$5.00 million$4.80 millionViewN/AView Earnings Details
11/6/2014Q314($0.51)($0.39)$5.95 million$6.00 millionViewN/AView Earnings Details
3/31/2014Q413($3.35)$0.87$5.45 million$5.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amedica (NASDAQ:AMDA)
Current Year EPS Consensus Estimate: $-1.03 EPS
Next Year EPS Consensus Estimate: $-0.40 EPS

Dividends

Dividend History for Amedica (NASDAQ:AMDA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Amedica (NASDAQ:AMDA)
Insider Ownership Percentage: 0.60%
Institutional Ownership Percentage: 3.24%
Insider Trades by Quarter for Amedica (NASDAQ:AMDA)
Insider Trades by Quarter for Amedica (NASDAQ:AMDA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/10/2015Ty LombardiVPBuy25,000$0.40$10,000.00View SEC Filing  
12/11/2014David W TruetzelDirectorSell15,000$0.68$10,200.00View SEC Filing  
12/8/2014Jeffrey S WhiteDirectorBuy9,600$0.62$5,952.00View SEC Filing  
2/18/2014David W TruetzelDirectorBuy5,000$5.82$29,100.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Amedica (NASDAQ:AMDA)
Latest Headlines for Amedica (NASDAQ:AMDA)
Source:
DateHeadline
finance.yahoo.com logoAmedica Announces Delayed Filing of Quarterly Report on Form 10-Q and Receipt of Nasdaq Letter
finance.yahoo.com - May 26 at 3:45 PM
americanbankingnews.com logoAmedica (AMDA) Earns Coverage Optimism Score of 0.44
www.americanbankingnews.com - April 29 at 9:08 AM
americanbankingnews.com logoAmedica (AMDA) Earning Somewhat Favorable News Coverage, Report Finds
www.americanbankingnews.com - April 25 at 2:31 PM
americanbankingnews.com logoAmedica Co. (AMDA) Earns Buy Rating from Maxim Group
www.americanbankingnews.com - April 24 at 3:44 PM
streetinsider.com logoAmedica (AMDA) Announces Regulatory Clearance to Market and Sell Valeo Silicon Nitride Spinal Implants in Australia - StreetInsider.com
www.streetinsider.com - April 24 at 3:30 PM
finance.yahoo.com logoAmedica Announces Regulatory Clearance to Market and Sell Valeo(R) Silicon Nitride Spinal Implants in Australia
finance.yahoo.com - April 24 at 10:45 AM
americanbankingnews.com logoSomewhat Critical Media Coverage Likely to Affect Amedica (AMDA) Share Price
www.americanbankingnews.com - April 20 at 11:34 AM
streetinsider.com logoAmedica (AMDA) Delays 10-K; Receives NASDAQ Delisting Notice - StreetInsider.com
www.streetinsider.com - April 20 at 1:30 AM
streetinsider.com logoForm 8-K AMEDICA Corp For: Apr 18 - StreetInsider.com
www.streetinsider.com - April 19 at 7:34 AM
finance.yahoo.com logoAmedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter
finance.yahoo.com - April 19 at 7:34 AM
prnewswire.com logoMedical Appliances Stocks on Investors' Radar -- Wright Medical, Amedica, MiMedx, and Accuray - PR Newswire (press release)
www.prnewswire.com - March 27 at 3:36 PM
us.rd.yahoo.com logoAmedica Announces Results of Independent Femoral Head Wear Testing
us.rd.yahoo.com - February 28 at 8:56 AM
us.rd.yahoo.com logo9:01 am Amedica announces completion of a hip simulator study examining the wear behavior of an advanced highly cross-linked and vitamin E stabilized polyethylene against two different types of ceramic femoral heads and BIOLOXdelta
us.rd.yahoo.com - February 28 at 8:56 AM
biz.yahoo.com logoAMEDICA CORP Files SEC form 8-K, Other Events
biz.yahoo.com - February 27 at 3:37 PM
streetinsider.com logoAmedica (AMDA) Granted Extension to Regain Compliance with Nasdaq Minimum Bid Price
www.streetinsider.com - February 16 at 8:35 PM
streetinsider.com logoAmedica (AMDA) Granted Extension to Regain Compliance with Nasdaq Minimum Bid Price
www.streetinsider.com - February 16 at 8:35 PM
streetinsider.com logoAmedica (AMDA) Granted Extension to Regain Compliance with Nasdaq Minimum Bid Price - StreetInsider.com
www.streetinsider.com - February 16 at 8:23 AM
finance.yahoo.com logoAmedica Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule
finance.yahoo.com - February 16 at 8:23 AM
biz.yahoo.com logoAMEDICA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
biz.yahoo.com - February 16 at 8:23 AM
finance.yahoo.com logo7:22 am Amedica receives notification from the NASDAQ indicating that the Co will have an additional 180-day grace period, until August 14, 2017, to regain compliance with NASDAQ's $1.00 minimum bid requirement
finance.yahoo.com - February 16 at 8:23 AM
biz.yahoo.com logoAMEDICA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - January 24 at 8:52 PM
biz.yahoo.com logoAMEDICA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
biz.yahoo.com - January 20 at 9:22 PM

Social

Chart

Amedica (AMDA) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff